FDA establishes its Oncology Center of Excellence
The FDA announced yesterday that it has established its Oncology Center of Excellence and appointed Dr. Richard Pazdur as the director. The center will help expedite the development of oncology-related medical products and encourage an integrated approach when evaluating drugs, biologics and devices for cancer treatment.

The agency believes that leveraging the expertise of regulatory scientists and reviewers will improve its ability to approve safe and effective cancer products as part of the National Cancer Moonshot Initiative. The goal of the initiative is to bring about a decade’s worth of advances in five years....